High expression of TIM-3 can occur in the peripheral blood (PB) and bone marrow (BM) of MM patients, but the expression of the three ligands of Tim-3 differs in different myeloma cell lines. This evidence concerns the gene HAVCR2 and Miyoshi myopathy.